L. Villa

Impact of the CYP2D6 polymorphism on steady-state plasma concentrations and clinical outcome of donepezil in Alzheimer’s disease patients

G. Lombardi, G. Miglio, M. Dahl, 2006, European Journal of Clinical Pharmacology.

P.5.a.010 Impact of CYP3A4 polymorphisms on donepezil plasma levels and therapeutic outcome

G. Lombardi, G. Miglio, M. Dahl, 2007, European Neuropsychopharmacology.

Do CYP3A and ABCB1 genotypes influence the plasma concentration and clinical outcome of donepezil treatment?

S. Fallarini, G. Lombardi, M. Dahl, 2010, European Journal of Clinical Pharmacology.

Handgrip impairment in Charcot-Marie-Tooth disease.

M. Calicchio, P. Vinci, P. Di Gianvito, 2005, Europa medicophysica.